Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vancomycin Prophylaxis for Recurrent CDI
NCT03466502Phase 4Completed
- Sponsor
- University of Nevada, Reno
- Start
- Mar 2018
- Primary completion
- Feb 2022
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Clostridium difficile infection (CDI), sponsored by University of Nevada, Reno. Started Mar 2018; status: completed.
02
Drugs
vancomycin
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03466502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03466502.